Cooperative Agreement NU62PS924608

The Centers for Disease Control and Prevention awarded a cooperative agreement to the City and County of San Francisco Public Health Department on September 30, 2025, totaling $643,882, obligated in full. The award funds the Medical Monitoring Project (MMP), a case surveillance activity that describes the behavioral and clinical characteristics of people with HIV in and out of care in San Francisco. The MMP uses surveillance-based sampling to supplement core HIV surveillance, generating data...

The Centers for Disease Control and Prevention awarded Houston Department of Health and Human Services a $1.463690 million cooperative agreement on September 30, 2025, to implement the Medical Monitoring Project in Houston and Harris County, Texas, under CFDA 93.940 (HIV Prevention and Surveillance Activities—Health Department Based). The Medical Monitoring Project is a key component of the National HIV Surveillance System designed to inform local and national HIV prevention and treatment...

The Centers for Disease Control and Prevention awarded a cooperative agreement totaling $2.613 million to the New York City Department of Health and Mental Hygiene on September 30, 2025, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944) to support the Medical Monitoring Project (MMP). The award funds HIV surveillance activities performed in New York, NY, with a period of performance extending through September 29,...

The Centers for Disease Control and Prevention awarded a $1,543,878 cooperative agreement to the Indiana Department of Health on September 30, 2025, under the HIV/AIDS Surveillance program (CFDA 93.944) to operate the Indiana Medical Monitoring Project, a supplemental HIV/AIDS surveillance system running through September 29, 2030. The Indiana MMP will collect clinical and behavioral data from a probability sample of 400 HIV-infected persons receiving and non-receiving care in Indiana,...

The Centers for Disease Control and Prevention's National Center for HIV/AIDS awarded the New Jersey Department of Health a $2.694 million cooperative agreement on September 30, 2025, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944) to operate the Medical Monitoring Project through September 29, 2030. The Medical Monitoring Project collects behavioral and clinical data on a probability sample of adults diagnosed...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded the Illinois Department of Public Health $3.723 million through a cooperative agreement on September 30, 2025, to conduct the Medical Monitoring Project under the HIV Prevention and Surveillance Activities–Health Department Based program (CFDA 93.940). The Medical Monitoring Project collects HIV surveillance and epidemiologic data to support HIV care and prevention planning bodies and service providers...

The Centers for Disease Control and Prevention awarded a $1.376 million cooperative agreement to the Michigan Department of Health and Human Services on September 30, 2025, under the HIV/AIDS Surveillance program (CFDA 93.944) to support the Medical Monitoring Project through September 29, 2030. Michigan conducts participant interviews and medical record abstractions to assess quality of care, guide resource allocation, and contribute to national HIV care improvement efforts. The Medical...

The Centers for Disease Control and Prevention awarded a $1.185 million cooperative agreement to Health Research, Inc. on September 30, 2025, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944) to conduct a Medical Monitoring Project. Health Research, Inc., operating as Health Research At The Aids Institute and headquartered in Menands, New York, is a tax-exempt nonprofit providing HIV/AIDS care, prevention, and public...

The Centers for Disease Control and Prevention awarded a $1.366 million cooperative agreement to the North Carolina Department of Health and Human Services on September 30, 2025, under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance program (CFDA 93.944). The award funds the Medical Monitoring Project, a surveillance initiative supporting HIV incidence and prevalence monitoring throughout the United States and its territories to inform HIV...

The National Institute of Mental Health awarded $812,484 to The Trustees of the University of Pennsylvania on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to test the effectiveness and dissemination of a digital intervention promoting home HIV testing and linkage to PrEP among men who have sex with men in Philadelphia. The project will randomize approximately 1,000 MSM participants to an experimental arm receiving tailored social-media and SMS messages...